In vitro activities of the new antifungal triazole SCH 56592 against common and emerging yeast pathogens
about
Antifungal activity and pharmacokinetics of posaconazole (SCH 56592) in treatment and prevention of experimental invasive pulmonary aspergillosis: correlation with galactomannan antigenemiaIn vitro activities of posaconazole (Sch 56592) compared with those of itraconazole and fluconazole against 3,685 clinical isolates of Candida spp. and Cryptococcus neoformansEvaluation of Etest method for determining posaconazole MICs for 314 clinical isolates of Candida speciesIn vitro activity of posaconazole against clinical isolates of dermatophytesSynthesis and in vitro antifungal and cytotoxicity evaluation of thiazolo-4H-1,2,4-triazoles and 1,2,3-thiadiazolo-4H-1,2,4-triazoles.Activities of available and investigational antifungal agents against rhodotorula speciesInteractions between triazoles and amphotericin B against Cryptococcus neoformans.New investigational antifungal agents for treating invasive fungal infections.Saccharomyces cerevisiae fungemia: an emerging infectious disease.In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts.Posaconazole plasma concentrations in juvenile patients with invasive fungal infection.Emerging azole antifungals.Posaconazole: clinical pharmacology and potential for management of fungal infections.Activity of posaconazole in the treatment of central nervous system fungal infections.Antifungal therapies in the intensive care unit.Therapeutic drug monitoring of voriconazole and posaconazole for invasive aspergillosis.Invasive Saccharomyces cerevisiae in a liver transplant patient: case report and review of infection in transplant recipients.Efficacy and safety of posaconazole in hematopoietic stem cell transplantation patients with invasive fungal disease.Risk of fungemia due to Rhodotorula and antifungal susceptibility testing of Rhodotorula isolates.Synthesis and biological evaluation of hydrazone derivatives as antifungal agents.In vitro interactions of micafungin with other antifungal drugs against clinical isolates of four species of Cryptococcus.Head-to-head comparison of the activities of currently available antifungal agents against 3,378 Spanish clinical isolates of yeasts and filamentous fungi.3-Benzyl-sulfanyl-5-(4-phenyl-1H-1,2,3-triazol-1-ylmeth-yl)-4H-1,2,4-triazol-4-amine.Differential azole antifungal efficacies contrasted using a Saccharomyces cerevisiae strain humanized for sterol 14 alpha-demethylase at the homologous locus.New agents for the treatment of systemic fungal infections--current status.New alkaloid from Streptomyces koyangensis residing in Odontotermes formosanus.
P2860
Q28349552-75CCD438-B688-4DF8-BEA8-E123E8E714A0Q28353303-49617DC9-6000-4DE5-90B8-04C0DA103C5BQ28362760-714110CF-C1CD-4C1C-96E0-B7A17A22B086Q28362768-EC6CA88B-740A-4495-89C9-3796187244F7Q31618008-793E2D97-76DB-4828-9C92-C5D232F72171Q33210616-A01EEC42-DAE0-4894-8307-D9E62805E2FDQ33980497-009196FA-F94F-45D9-BEB8-05B815AD595DQ34075014-8320B4DF-BB3A-4E0F-B0E6-077A55742EC1Q34557580-C1DFE3FB-86B9-4BF9-89BB-DD19A9A40F8CQ34680661-C389B052-07AA-4F5B-987C-1882F3703AB0Q35647678-1AD9A967-D906-47E3-9662-EAB30BA11816Q36066009-E1299F5D-8137-4B46-8D9D-3C5C5515DDD5Q36233491-AFFCEE7E-B172-429E-8F0D-B2C77C00DA3DQ36246196-52E9128A-2C01-458D-8A72-631574FCE0BBQ37161793-74ED4AFE-FA9B-4FBA-B605-379CF254917EQ38140015-59B11DF5-F69C-423B-8D45-C8713CDC7216Q38397662-ADFE27CB-2550-4E0A-9FFC-F0CEA9512681Q40062960-A28EAACF-7D59-4506-99C2-731364355DE9Q40172988-02B486CC-62DC-40BB-9190-617814E4319CQ41204306-78FE34E5-1A31-47CA-A7D0-F56BFD79434DQ41772012-8AADF592-74C4-4332-88CE-C689D70EF7D0Q41842788-92FD3764-EEEC-46FD-B0ED-DE02478C1F67Q42401578-6F884240-9B64-4A56-8E9A-4D4BD220C78BQ43190364-11905DA6-FC42-4FB7-B15B-05CFC96FE6D0Q46576615-FE495099-9D3E-434B-94A6-CE64C90587EBQ52751375-E8F60314-25DC-4BB4-8006-4B19F3EED058
P2860
In vitro activities of the new antifungal triazole SCH 56592 against common and emerging yeast pathogens
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
In vitro activities of the new ...... n and emerging yeast pathogens
@ast
In vitro activities of the new ...... n and emerging yeast pathogens
@en
In vitro activities of the new ...... n and emerging yeast pathogens
@nl
type
label
In vitro activities of the new ...... n and emerging yeast pathogens
@ast
In vitro activities of the new ...... n and emerging yeast pathogens
@en
In vitro activities of the new ...... n and emerging yeast pathogens
@nl
prefLabel
In vitro activities of the new ...... n and emerging yeast pathogens
@ast
In vitro activities of the new ...... n and emerging yeast pathogens
@en
In vitro activities of the new ...... n and emerging yeast pathogens
@nl
P2093
P2860
P1476
In vitro activities of the new ...... n and emerging yeast pathogens
@en
P2093
A W Fothergill
F Barchiesi
L F Di Francesco
M G Rinaldi
P2860
P356
10.1128/AAC.44.1.226-229.2000
P407
P577
2000-01-01T00:00:00Z